Abstract:
Hyaluronic acid is an anionic, nonsulfated glycosaminoglycan distributed widely throughout connective, epithelial, and neural tissues. It is unique among glycosaminoglycans in that it is nonsulfated, forms in the plasma membrane instead of the Golgi apparatus, and can be very large, with its molecular weight often reaching the millions. One of the chief components of the extracellular matrix, hyaluronan contributes significantly to cell proliferation and migration, and may also be involved in the progression of some malignant tumors.
The global Hyaluronic Acid market is valued at 6500 million US$ in 2018 is expected to reach 13400 million US$ by the end of 2025, growing at a CAGR of 9.5% during 2019-2025.
Get the Complete Report @ https://www.24chemicalresearch.com/reports/25167/global-hyaluronic-acid-2019-387
The rising popularity of minimal-invasive procedures and the cost-effectiveness of non-surgical procedures is driving the adoption of non-surgical cosmetic procedures across the globe. Technavio’s research analysis on the global hyaluronic acid market identifies that this increased adoption of non-surgical cosmetic procedures will be one of the major factors that will have a positive impact on the market’s growth during the next few years. Dermal fillers, chemical peels, laser treatments, microdermabrasion, and botulinum toxin are some of the major non-surgical procedures. Hyaluronic acid (HA), calcium hydroxylapatite, polyalkylimide, polylactic acid, and polymethyl-methacrylate microspheres are the major types of dermal fillers. Hyaluronic acid injection helps in the reduction of damage caused by scars, wounds, or lines. It is also used to improve the contour of the skin. This will consequently increase the demand for hyaluronic acid for cosmetic procedures, fueling market growth.
North America is witnessing considerable growth of the hyaluronic acid market due to the rising demand for treatments in the medical and cosmetic sectors. The region’s healthcare sector is well advanced and there are a number of high-quality medical facilities. Consumers in this region give more importance to anti-aging treatments such as plastic surgery. This in turn, will drive the demand for Hyaluronic acid (HA) in the region. Moreover, the adoption of HA will also increase with the growing instances of osteoarthritis.
This report focuses on Hyaluronic Acid volume and value at global level, regional level and company level. From a global perspective, this report represents overall Hyaluronic Acid market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers Of Hyaluronic Acid are covered:
- ALLERGAN
- Anika Therapeutics
- Sanofi
- SEIKAGAKU
- Zimmer Biomet
Hyaluronic Acid Segment by Regions
- North America
- Europe
- China
- Japan
Hyaluronic Acid Segment by Type
- Five-Injection Cycle
- Single-Injection Cycle
- Three-Injection Cycle
Hyaluronic Acid Segment by Application
- Vesicoureteral Reflux
- Ophthalmic Surgery
- Osteoarthritis
- Dermal Fillers
Get more information from Table of Content@ https://www.24chemicalresearch.com/reports/25167/global-hyaluronic-acid-2019-387#toc
CONTACT US:
North Main Road Koregaon Park, Pune, India - 411001.
International: +1(646)-781-7170
Asia: +91 8329744015
Email: [email protected]
Follow Us On linkedin :- https://www.linkedin.com/company/24chemicalresearch/
